semaglutide 2.4 Weight-loss drug Wegovy produces 'largest benefit ever seen' for patients with most common form of heart failure, trial finds Wegovy was approved by the Food and Drug Administration (FDA) in 2021 and is marketed by Novo Nordisk How Many Units Is 2.4
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23




























